Immune complex nephropathies in patients with malignant tumours

Area of Science:

• Nephrology
• Oncology
• Immunopathology

Background:

• Malignant tumors can affect various organs, including the kidneys.
• Immune complex glomerulonephritis is a kidney disease characterized by immune deposits in the glomeruli.
• The link between cancer and kidney pathology, particularly glomerulonephritis, requires further investigation.

Purpose of the Study:

• To investigate the incidence and characteristics of immune complex glomerulonephritis in postmortem kidney specimens from cancer patients.
• To correlate pathological findings with clinical symptoms in patients with malignant tumors and kidney damage.

Main Methods:

• Analysis of 23 postmortem kidney specimens from patients with malignant tumors (18 solid tumors, 5 leukemias).
• Utilized light microscopy and immunofluorescence techniques to examine kidney tissue.
• Assessed for specific types of glomerulonephritis and immunoglobulin/complement deposition.

Main Results:

• Light microscopy revealed diffuse mesangial proliferative glomerulonephritis in 4 kidneys and focal mesangial proliferative glomerulonephritis in 2 kidneys.
• One case of IgA glomerulonephritis was identified.
• Granular immunoglobulin deposition in the mesangium, with C3 in some cases, was observed in 5 kidneys.
• Clinical symptoms of kidney damage were present in only 2 patients.
• No Carcinoembryonic antigen (CEA) or alpha-fetoprotein (alpha FP) were detected in diseased kidneys.

Conclusions:

• Glomerular damage, indicative of immune complex glomerulonephritis, is not uncommon in patients with malignant tumors.
• This kidney pathology often presents with minimal or no overt clinical symptoms.
• The findings suggest a potential paraneoplastic effect of tumors on renal glomeruli.